Wendy B. Young
Director · ADIAL PHARMACEUTICALS, INC.
IndividualBuying only
- 2024
- Sep 21, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Wendy B. Young files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Coastlands Capital LP - $106K in ADIL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Wendy B. Young?
Wendy B. Young is a corporate insider, tracked as Director of ADIAL PHARMACEUTICALS, INC. (ADIL). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Wendy B. Young submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Wendy B. Young been buying or selling stock?
Recorded transactions: 2 open-market purchases ($179K) and 0 open-market sales across all tracked filings.
